NASDAQ · Healthcare · Biotechnology
CytoMed Therapeutics Limited
GDTC
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. CEO Chee Kong Choo · Market cap $11.2M.
$0.95
+0.10 · +12.30%
52w hi $3.6852w lo $0.68
Off 52w high 73.1%
60
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
0 strong · 3 notable
Analyst consensus
Hold
—
Section 01
Recent Form 4 filings
3 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jul 20 | Chee Kong Choo | Buy | 100,000 | $1.50 | +$150K | 60 | |
| Jul 14 | Chee Kong Choo | Buy | 100,000 | $1.50 | +$150K | 60 | |
| May 13 | Chee Kong Choo | Buy | 112,000 | $1.15 | +$129K | 64 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug